A roundabout was selected in one of two East Berlin Road improvement projects near Hampton in eastern Adams County, according ...

Discusses Technology and Digital Innovation Driving Growth in Animal Health January 23, 2026 4:00 PM ESTCompany ...

Capital One Financial Corporation ( COF) Q4 2025 Earnings Call January 22, 2026 5:00 PM EST Good day, and thank you for standing by. Welcome to the Capital One Q4 2025 Earnings Call. Please be advised ...

More than three years after a 500-year flood event wiped out Yellowstone National Park’s North Entrance Road in June 2022, the park is nearing selection of a route ...

The proposal pushes Washington and Kyiv closer to a jointly agreed formula to end the war. What we know on day 1,401 Ukrainian president Volodymyr Zelenskyy has said he would be willing to withdraw ...

The northbound connector ramp between U.S. 183 express lanes and MoPac Expressway/Texas State Highway Loop 1 will open Saturday, January 31, according to officials with the 183 North Mobility ...

Zelenskyy Says He's Open to Creating Demilitarized Zone in Ukraine's Industrial Heartland KYIV, Ukraine (AP) — Ukrainian President Volodymyr Zelenskyy said he would be willing to withdraw troops from ...

KYIV, Ukraine (AP) — Ukrainian President Volodymyr Zelenskyy said he would be willing to withdraw troops from the country’s eastern industrial heartland as part of a plan to end Russia’s war, if ...

Add Yahoo as a preferred source to see more of our stories on Google. Ukrainian servicemen attend a parade on Orthodox Christmas eve in downtown Lviv, Ukraine, on Wednesday, Dec. 24, 2025. (AP ...

U.S. stock markets, including the NYSE and Nasdaq, will resume normal trading hours on the day after Christmas. Markets will close early on New Year's Eve and remain closed on New Year's Day. Many ...

Ukrainian President Volodymyr Zelenskyy said he would be willing to withdraw troops from the country’s eastern industrial heartland as part of a plan to end Russia’s war, if Moscow also pulls back and ...

– Overall survival update for Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients planned in coming weeks – NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Immuneering ...